Frank E Blaney

Modeling the pore structure of voltage-gated sodium channels in closed, open, and fast-inactivated conformation reveals details of site 1 toxin and local anesthetic binding

Holger Scheib, Nicolas Guex, N. Guex, 2006, Journal of molecular modeling.

Novel 5-HT(1A/1B/1D) receptors antagonists with potent 5-HT reuptake inhibitory activity.

Paul W Smith, C. Scott, F. Blaney, 2008, Bioorganic & medicinal chemistry letters.

Unifying family A GPCR theories of activation.

Benjamin G Tehan, Andrea Bortolato, Jonathan S Mason, 2014, Pharmacology & therapeutics.

Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.

G. W. Price, F. Blaney, A. Medhurst, 2003, Molecular pharmacology.

CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.

I. Forbes, F. Blaney, A. Bridges, 2003, Journal of medicinal chemistry.